Global Diabetes Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that’s made by an organ called the pancreas. When the body doesn’t make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems – including blindness, kidney damage, heart disease and stroke. That’s why it’s important to take medicine that helps lower blood sugar levels. Diabetes can be managed so you can live a normal, healthy life. All diabetes drugs work to lower the levels of sugar in the blood. There are two basic types of diabetes drugs: pills by mouth and shots injected into the skin. More than one drug is often needed to manage diabetes. Some people try different pills, take more than one pill, or take a pill along with shots. Scope of the Report: As World overall economic downward trend in the past few years, and int ...
Table of Contents 1 Market Overview 1.1 Diabetes Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Sulphonylureas 1.2.2 Biguanides 1.2.3 Meglitinides 1.2.4 Thiazolidinediones 1.2.5 Alpha-glucosidase Inhibitors 1.2.6 DPP-4 Inhibitors 1.2.7 SGLT-2 Inhibitors 1.3 Market Analysis by Applications 1.3.1 Application I 1.3.2 Application II 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russi ...
1840

1808

OUR CLIENT